Novartis Patient Support

Image of A group of women in workout gear sitting together after a yoga class.

Novartis Patient Support™

Personalized support that can help you start, stay, and save on treatment

Once you’ve been prescribed KISQALI, you or your loved one can sign up for Novartis Patient Support. It’s a comprehensive program with a dedicated team in your corner.

Getting started

What does personalized support mean?

You’ll have a team you can count on with Novartis Patient Support. They’ll reach out from the start and get to know you. When you have questions, you can talk to them directly.*

*Novartis Patient Support does not provide clinical advice and is not a substitute for consulting with your health care provider.

Ready to sign up?

A helping hand when you need it

Novartis Patient Support offers options for saving on your prescriptions, insurance verification, and other ongoing support.

Financial support

How can I save on my KISQALI?

The list (or wholesale) price for KISQALI, as of February 24, 2025, is $15,280 per 28-day cycle for a 400-mg dose strength or $19,100 per 28-day cycle for a 600-mg dose strength. The list price may not reflect the price paid by patients; most patients with prescription coverage will pay less.

Cost shouldn’t be a barrier between you and the treatment you need. Your support will be based on your unique financial situation. That will include things like your prescription and insurance coverage. Novartis Patient Support offers options to help you afford your treatment.

What is Co-Pay Plus?

If eligible, Co-Pay Plus may help you pay for your KISQALI, including refills. Co-Pay Plus is not health insurance but can help cover out-of-pocket expenses related to your prescription. For more details, download the Co-Pay Plus brochure.

Pay as little as $0* with Co-Pay Plus

Eligible patients with private insurance may pay as little as $0
Be mindful of your annual benefit limit

3 ways to sign up for Novartis Patient Support

Once your health care provider prescribes you KISQALI, you can:

Sign up now

Enter your information on our secure site.

Call
866-433-8000

Monday-Friday, 8:00 AM to 8:00 PM ET, excluding holidays. Your dedicated Novartis Patient Support team can then help you sign up.

Ask your provider

Your health care provider and/or their office staff can help you sign up.

Co-Pay Plus Terms & Conditions.

Offer valid only when used with commercial health insurance. Offer is not available where:

the patient has federal or state health plan benefits (e.g., Medicare, Medicaid, TRICARE, VA);
the health plan reimburses for the entire cost of the drug;
the health plan provides no coverage for the drug; or prohibited by law.

The amount of funding available from the Program is subject to an annual limit. Novartis reserves the right to discontinue the availability of co-pay assistance if, at any time, Novartis determines that the patient is subject to a co-pay maximizer program. Co-pay maximizers are programs implemented by health plans in which the amount of the patient’s out-of-pocket cost is increased to reflect the availability of support offered by a manufacturer assistance program. The patient is responsible for all costs once available funding from the Program is exhausted.

The Program is designed exclusively for the benefit of the patient. The amount of available funding may be reduced or eliminated if it is not credited by the patient’s health plan toward the patient’s out-of-pocket obligations (e.g., deductibles, annual out-of-pocket maximums). Program funding may also be reduced or eliminated if the patient’s health plan, directly or indirectly, adjusts, reduces, or waives the patient’s health plan benefits based on the availability of, or the patient’s enrollment in, the Program, or otherwise acts in a manner that materially affects these Terms and Conditions.

Only the patient or their legal guardian or caregiver may enroll the patient in the Program. Health plans, specialty pharmacies, pharmacy benefit managers, and their agents and representatives (individually and collectively “Plan Administrators”), are prohibited from enrolling patients in the Program.

Patients in the Program are responsible for notifying Novartis of any change in their prescription drug health plan coverage that may conflict or otherwise affect compliance with these Terms and Conditions. By accepting Program funding from Novartis on behalf of participating patients, Plan Administrators agree to not take any action that materially affects compliance with these Terms and Conditions.

Patients may not seek reimbursement for the value received from the Program from any other party (e.g., health plans, flexible spending, or healthcare savings accounts). Patients are responsible for complying with any applicable limitations and requirements of their health plan related to their use of the Program.

Valid only in the United States and Puerto Rico. For purchasers of FEMARA only, this is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.

The Program is not health insurance, and may not be combined with any third-party rebate, coupon, or offer. Novartis reserves the right to rescind, revoke, or amend the Program at any time without notice.

What if I’m waiting for my insurance to kick in?

Your costs may be covered during this period

If your insurance coverage is denied or delayed, the Bridge Program can cover your costs during this period. You may get up to 5 months of KISQALI for free.^†This gives Novartis Patient Support time to assist you with processing your insurance.

^†The Bridge Program applies to KISQALI and the KISQALI FEMARA Co-Pack only. Eligible patients must have private insurance, a valid prescription for KISQALI and the KISQALI FEMARA Co-Pack, and a denial of insurance coverage based on a prior authorization requirement. Program requires the submission of a prior authorization and/or appeal of the coverage denial within the first 90 days of enrollment to remain eligible. Program provides KISQALI for free to eligible patients for up to 5 months, or until they receive insurance coverage approval, whichever occurs earlier. A valid prescription consistent with FDA-approved labeling is required. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to reverify insurance coverage status during the course of the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Additional limitations may apply. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.

What is the Free Trial Offer for KISQALI?

Sign up for 1 Treatment Cycle Free Trial Offer^‡

Your Free Trial Offer for KISQALI is good for 1 treatment cycle of your medication at no cost to you. This offer is available to all with a valid prescription—regardless of insurance. For one-time use only.

Get your first treatment cycle of KISQALI at no cost.

^‡No purchase required. This free trial is not health insurance. Void where prohibited by law. Product dispensed pursuant to terms and conditions of offer. Valid only in the US and Puerto Rico. For Massachusetts residents, offer is valid for one of the following: the KISQALI FEMARA Co-Pack or KISQALI and/or generic letrozole. Claims shall not be submitted to any public or private third-party payer or any federal or state health care program for reimbursement. Offer not valid if reproduced or submitted to any other payer. It is illegal for any person to sell, purchase or trade, or offer to sell, purchase or trade, or to counterfeit, this offer. Prescriber ID# is required on prescription. This is the property of Novartis Pharmaceuticals Corporation and must be returned upon request. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend offer without notice.

Insurance support

How can Novartis Patient Support help me navigate insurance coverage?

Supporting your start on KISQALI is our number one priority. Novartis Patient Support is here to help. You’ll work with an experienced team member who can:

Help you navigate the insurance process
Provide information to your health care provider designed to assist them with the insurance process
Assist you if there are changes to your health plan

Ongoing support

What if I need ongoing support after starting KISQALI?

Once you’ve started treatment, your Novartis Patient Support team will be there for you.

Live, one-on-one support is available to assist you with:

Guidance on your health plan coverage process
Options for saving on your prescription
Setting up your routine and getting more help with KISQALI
Educational resources about KISQALI and living with breast cancer
- A welcome kit to help you start on KISQALI
- Tips for talking to your health care provider
- A brochure to help answer many of your questions
A list of independent support organizations that can offer services to help with treatment
Your choice of texts, calls, and emails to keep you connected to ongoing support

Novartis Patient Support doesn’t replace medical guidance from your health care provider. Our goal is to help you feel informed about your treatment from day one.

Have questions?

Call Novartis Patient Support at 866-433-8000, Monday-Friday, 8:00 AM to 8:00 PM ET, excluding holidays.

If you have no insurance

There may be options available to you

Novartis Patient Assistance Foundation, Inc. (NPAF), an independent 501(c)(3) non-profit organization, provides Novartis medications free of cost to eligible patients who have limited or no prescription insurance coverage and cannot afford the cost of their medication.

To be eligible for NPAF, you must:

Reside in the United States or a US Territory
Be treated by a licensed US health care provider on an outpatient basis
Meet income and insurance guidelines

Visit PAP.novartis.com or call NPAF at 1-800-277-2254 to learn more about eligibility and how to apply.